Related Experiment Videos
Langerhans cell depletion in gliotoxin-treated murine epidermis
P C McMinn1, G M Halliday, P Waring
1Department of Pathology, University of Tasmania, Hobart, Australia.
Insights
The fungal metabolite gliotoxin significantly reduces Langerhans cells (LC), crucial for skin immunity, by 30-35%. This depletion persists for 13 weeks, suggesting potential immunosuppressive applications.
Area of Science:
- Immunology
- Dermatology
- Mycology
Background:
- Langerhans cells (LC) are epidermal dendritic cells vital for initiating cutaneous immune responses.
- Gliotoxin, a fungal metabolite from Aspergillus fumigatus, exhibits immunomodulating properties and is explored for immunosuppression.
Purpose of the Study:
- To investigate the effect of epicutaneously applied gliotoxin on epidermal Langerhans cells.
- To determine the concentration-dependent toxicity and duration of gliotoxin's impact on LC.
Main Methods:
- Epicutaneous administration of gliotoxin to skin explants or animal models.
- Quantification of epidermal LC numbers and morphological assessment via microscopy.
- Electron microscopy to evaluate cellular damage at the ultrastructural level.
Main Results:
- Gliotoxin application reduced epidermal LC numbers by 30-35% with morphological alterations.
- Selective damage to LC was observed at nanomolar concentrations, sparing adjacent keratinocytes.
- LC depletion persisted for up to 13 weeks post-treatment.
Conclusions:
- Gliotoxin selectively targets and depletes epidermal Langerhans cells.
- The prolonged depletion suggests potential systemic effects or sustained local retention of gliotoxin.
- Findings support gliotoxin's potential as an agent for modulating skin immunity or for transplantation therapy.
Abstract:
Langerhans cells (LC) are dendritic antigen presenting cells of bone marrow origin which reside in the suprabasal layer of the epidermis. They express high concentrations of Class II MHC glycoproteins on their plasma membrane and transport cutaneous antigen to local lymph nodes for presentation to helper T cells. They are thus essential for the induction of cutaneous immunity. Gliotoxin is a member of the epipolythiodioxopiperazine (ETP) group of fungal metabolites, derived from the human pathogen Aspergillus fumigatus. It has been shown to have immunomodulating properties in vivo and in vitro, and has been proposed as a potential immunosuppressant for transplantation therapy. Epicutaneous application of gliotoxin reduced the numbers of epidermal LC by 30-35 per cent with an associated morphological change from highly dendritic to a more rounded form. Electron microscopic studies showed selective damage to LC at very low (nM) concentrations of gliotoxin, with no obvious effect on adjacent keratinocytes. LC numbers remained depleted for 13 weeks after initial treatment, suggesting that systemic suppression or prolonged retention of gliotoxin within the skin may play a role in its mechanism of action.